Table 2.
Comparison of SCLC patients according to the presence of NTIS
| Patient characteristics | NTIS (−) | NTIS (+) | p |
|---|---|---|---|
| Age (years) | 57 (49–65) | 61 (53–67) | 0.17 |
| BMI (kg/m2) | 27 (25–29) | 15 (22–25) | 0.000 |
| Albumin (g/dl) | 4.1 (3.8–4.5) | 2.7 (2.2–3.4) | 0.000 |
| Cholesterol (mg/dl) | 213 (196–241) | 183 (166–234) | 0.013 |
| ECOG score | 1 (1–2) | 3 (2–4) | 0.000 |
| Hb (g/dl) | 13.2 (11.9–13.4) | 11.8 (10.2–13.9) | 0.19 |
| Lymphocyte (cell/mm3) | 1,456 (1,332–1,546) | 1,320 (1,127–1,730) | 0.048 |
| Survival (days) | 320 (218–423) | 50 (32–125) | 0.000 |
SCLC small-cell lung cancer, NTIS non-thyroid illness syndrome, BMI body mass index, ECOG eastern cooperative oncology group, Hb hemoglobin